• GRE Suppresses Melanogenesis via CREB/MITF

  2026-08-23

  The reference study examines glabridin, resveratrol, and ellagic acid as a combined GRE composition with anti-melanogenic, antioxidant, and anti-inflammatory activity in cell-based assays. Its principal mechanistic contribution is connecting reduced melanin production with inhibition of CREB phosphorylation and downstream MITF-associated pigmentation programs, while also defining important limits for translation to hyperpigmentation disorders.

• CHIR-99021: From GSK-3 to Translational Stemness

  2026-08-22

  CHIR-99021 and CT99021 offer a precise route to interrogate GSK-3, Wnt/β-catenin signaling, stemness, and regenerative cell-state transitions while exposing the assay controls required for translational confidence.

• Isoprenaline Hydrochloride: Cardiac β-Agonist Models

  2026-08-21

  Isoprenaline Hydrochloride, also called isoproterenol, is a non-selective β-adrenergic agonist for controlled cardiac, airway, endothelial, and heart–brain axis experiments. Its β1- and β2-receptor activity supports cardiac arrhythmia research and bronchospasm research, while defined cell and animal examples provide starting points for assay development.

• Thiazovivin (A5506): ROCK Inhibitor Workflow Guide

  2026-08-20

  Thiazovivin (SKU A5506) is a ROCK inhibitor for workflows involving fibroblast reprogramming, induced pluripotent stem cell generation, and human embryonic stem cell recovery after trypsinization. This guide explains practical handling and QC boundaries; it is intended for controlled in vitro stem cell research, not diagnostic, therapeutic, or medical use.

• Concanamycin A Workflow for V-ATPase Studies

  2026-08-20

  Concanamycin A provides a rapid, nanomolar way to connect V-ATPase activity with organelle acidification, apoptosis, trafficking, and tumor-cell invasion. This workflow combines practical dosing guidance with a cautious, hypothesis-generating bridge to phosphorylation-regulated sphingolipid biology.

• Vacuolin-1: Reliable Lysosomal Exocytosis Workflows

  2026-08-19

  Learn how Vacuolin-1 (SKU C4084) can help separate Ca2+-dependent lysosomal exocytosis from cell loss and broader trafficking effects. This scenario-based guide covers assay design, protocol optimization, disease-model interpretation, and practical product selection.

• β-Pseudouridine in RNA Workflow Design

  2026-08-19

  β-Pseudouridine is a solid modified nucleoside for dissecting RNA structure, modification biology, and translational fidelity—but it must not be confused with the triphosphate reagent used for direct RNA incorporation. This workflow connects practical reagent handling with the dose-sparing self-amplifying RNA findings reported for influenza vaccine research.

• LINC02870–EIF4G1–SNAIL Axis in HCC

  2026-08-18

  The reference study identifies LINC02870 as a potentially oncogenic long non-coding RNA that promotes hepatocellular carcinoma progression by engaging EIF4G1 and increasing SNAIL translation. Its combination of clinical expression analysis, prognostic modeling, cellular perturbation, and mechanistic investigation provides a useful framework for studying lncRNA control of translation in HBV-associated HCC.

• Levofloxacin: From DNA Gyrase to Bone Assays

  2026-08-18

  Levofloxacin is a synthetic fluoroquinolone antibiotic with applications spanning bacterial DNA replication studies and bone-cell assays. This guide presents a mechanistically resolved workflow for separating antibacterial activity, osteoblast growth inhibition, calcium deposition, and cartilage-matrix effects.

• Antimycin A4: ATP-Citrate Lyase Inhibitor Guide

  2026-08-17

  Antimycin A4 combines ATP-citrate lyase inhibition with mitochondrial respiratory-chain disruption, enabling linked studies of lipid synthesis, ATP production, and cellular stress. This practical guide covers assay design, concentration planning, orthogonal validation, and troubleshooting for more interpretable metabolism experiments.

• Rucaparib Beyond BRCA: A Translational PARP Roadmap

  2026-08-17

  Rucaparib provides a useful experimental lens for studying how PARP1 inhibition, DNA repair state, spliceosome regulation, and transporter biology shape treatment response. This article connects established radiosensitization findings in prostate cancer with emerging SmD2-dependent PARP inhibitor sensitivity in hepatocellular carcinoma while clearly separating evidence from forward-looking research strategy.

• Dehydroabietic Acid for Metabolic Assays

  2026-08-16

  Dehydroabietic acid provides a practical way to study coordinated PPAR-α and PPAR-γ biology across lipid handling, insulin responses, and hepatic metabolism. This workflow combines concentration-controlled cell assays with compartment-aware sampling concepts from a recent triacetin study, while clearly separating established product specifications from exploratory recommendations.

• Phalloidin (B7678): F-Actin Workflow Guide

  2026-08-15

  Phalloidin (B7678) is a high-affinity F-actin probe for preserving and visualizing filament organization in fixed, permeabilized cells, tissue sections, and cell-free assays. It is not an appropriate primary reagent for live-cell imaging or experiments that require reversible actin dynamics because it stabilizes filaments and can alter cytoskeletal behavior.

• Temafloxacin: From Target Biology to Translation

  2026-08-15

  Temafloxacin offers translational researchers a practical bridge between fluoroquinolone mechanism, pathogen-specific susceptibility, intracellular antibacterial testing, and historical tissue-exposure data. This thought-leadership article explains how to use the compound strategically in respiratory, atypical-pathogen, and resistance-focused research without confusing in vitro potency with clinical efficacy.

• SM-164 Workflows for IAP-Driven Apoptosis

  2026-08-14

  SM-164 is a bivalent Smac mimetic for dissecting IAP-controlled apoptosis with rapid cIAP-1 degradation and downstream caspase readouts. This practical guide connects cell-based dose finding, TNFα-dependent apoptosis assays, and orthogonal RNA Pol II studies while emphasizing formulation, controls, and interpretation.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page